Open an account

Phreesia

PHR · NYSE

$12.05+$0.77 (+6.83%)TodayMarket closed ·
Prev close $11.28

About PHR

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Wilmington, Delaware and currently employs 1,789 full-time employees. The company went IPO on 2019-07-18. The firm's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The firm's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.

Employees
1,789
Headquarters
Wilmington, Delaware
Listed
Jul 18, 2019
Sector
Health Care
Industry
Health Care Technology
Website
phreesia.com

PHR key statistics

Market cap
747.95M
Price-earnings ratio
66.35
Dividend yield
—
Average volume
649.90K
Volume
1.00M
Open price
$11.32
High today
$12.06
Low today
$11.30
52 Week high
$24.07
52 Week low
$7.77

Phreesia (PHR) at a glance

As of Oct 20, 2026, Phreesia (PHR) shares are priced at $12.05, giving the company a market cap of 747.95M and a price-to-earnings ratio of 66.35.

Today the stock has traded between $11.30 and $12.06. The current price is 6.7% above the day's low and 0.1% below its high.

Volume so far is 1.00M shares, above the average of 649.90K shares a day.

Over the past year Phreesia has ranged from $7.77 to $24.07, and now sits 26% of the way up that range.

Phreesia met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.03 per share against an estimate of $0.0862.

The average analyst price target is $14.35, 19.1% above the current price, from 17 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

53%of 17 analyst ratings say Buy
  • Buy52.9%
  • Hold47.1%
  • Sell0.0%
Price target · 16 analystsAvg $14.35
Low
$10.10
Now
$12.05
High
$21.00

PHR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 141.8% on average.

  1. Q2 FY25: reported -$0.31 per share against an estimate of -$0.3594
  2. Q3 FY25: reported -$0.25 per share against an estimate of -$0.2745
  3. Q4 FY25: reported -$0.11 per share against an estimate of -$0.1798
  4. Q4 FY26: reported $0.03 per share against an estimate of $0.0727
  5. Q1 FY27: reported $0.05 per share against an estimate of $0.0118
  6. Q1 FY26: reported $0.05 per share against an estimate of $0.0118
  7. Q2 FY27: reported $0.03 per share against an estimate of $0.0862
  8. Q2 FY26: reported $0.03 per share against an estimate of $0.0862

PHR news

  • Avi Kapoor

    Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

  • Press releaseBusiness Wire

    Phreesia’s Michael Rasbury Named to Becker’s 2026 List of Rising Stars: Healthcare Leaders Under 40

  • Press releaseBusiness Wire

    Phreesia to Support Parkinson’s Disease Awareness and Research with The Michael J. Fox Foundation

  • Press releaseBusiness Wire

    Phreesia Named to TIME’s 2026 List of the World’s Top HealthTech Companies

  • Press releaseBusiness Wire

    Phreesia’s ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 10 Health Care Stocks Whale Activity In Today’s Session

  • Press releaseBusiness Wire

    Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results

Similar companies

Companies in the same industry as Phreesia

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.